Biotech

Forget the recession. Or perhaps, thrive in spite of it. That seemed to be the prevailing mindset at the AllThingsLifeSciences 2009 Venture Capital Forum held in Madison on October 1, 2009. Total funding sought by all 18 women-owned life science companies presenting at...

Stratatech Corp., a Madison firm that produces cell-based skin substitutes for medical research and therapeutic applications, has been awarded a $1.7-million grant from the National Cancer Institute (NCI). Under the grant, Stratatech will begin development of a novel, cell-based gene therapy product targeted to the...

In a visit to the National Institutes of Health (NIH) campus, President Barack Obama announced $5 billion in grant awards under the American Recovery and Reinvestment Act of 2009 (Recovery Act) to fund cutting-edge medical research in every state across America. The more than...

The flight of promising biotech start-ups to Wisconsin does not bode well for Minnesota, a state that depends heavily on medical technology and devices for economic growth. Experts predict biotechnology will drive medical innovation over the next century and beyond. Wisconsin has become the regional...

Women CEOs of 18 early stage life science companies will gather at the Fluno Center in Madison on September 30th thru October 1st to compete for venture capital at the AllThingsLifeSciences 2009. Attendees will include regional and national investors seeking out promising early-stage companies. ...